65938-78-5 Usage
Description
2-Pyridinesulfonamide,4-methyl-(9CI), also known as 4-Methyl-2-pyridinesulfonamide, is a chemical compound belonging to the pyridinesulfonamide family. It features a 2-pyridinesulfonamide core structure with a methyl group attached to the 4-position of the pyridine ring. 2-Pyridinesulfonamide,4-methyl-(9CI) has the molecular formula C6H8N2O2S and is known for its diverse industrial and pharmaceutical applications, making it a valuable asset in chemical research and development.
Uses
Used in Chemical Synthesis:
2-Pyridinesulfonamide,4-methyl-(9CI) serves as a building block for the synthesis of other chemical compounds. Its unique structure and reactivity make it a versatile component in the creation of various organic molecules, contributing to the advancement of chemical research and development.
Used in Pharmaceutical Research:
As a potential drug candidate, 2-Pyridinesulfonamide,4-methyl-(9CI) is explored for the treatment of various diseases. Its properties and reactivity allow it to be a promising candidate for drug discovery, with the potential to be further developed and optimized for specific therapeutic applications.
Used in Chemical Research:
2-Pyridinesulfonamide,4-methyl-(9CI) is also utilized in chemical research to study its properties and reactivity. This knowledge can be applied to develop new synthetic methods, understand reaction mechanisms, and improve the overall efficiency of chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 65938-78-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,9,3 and 8 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 65938-78:
(7*6)+(6*5)+(5*9)+(4*3)+(3*8)+(2*7)+(1*8)=175
175 % 10 = 5
So 65938-78-5 is a valid CAS Registry Number.
65938-78-5Relevant articles and documents
TYK-2 INHIBITOR
-
, (2022/01/05)
Disclosed herein is a compound of Formula (I) for inhibiting TYK2 and treating a disease associated with the undesirable tyk-2 activity (tyk-2 related diseases), a method of using the compounds disclosed herein for treating inflammatory or autoimmune disease, and a pharmaceutical composition comprising the same.